Nelly Conus
Overview
Explore the profile of Nelly Conus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Conus N, Burgher-Kennedy N, van den Berg F, Kaur Datta G
Curr Med Res Opin
. 2018 Aug;
35(4):587-593.
PMID: 30106311
Objectives: Emulsified formulations of omega-3 fatty acids may increase plasma concentrations of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) compared with non-emulsified formulations. The current study evaluated plasma concentrations of...
2.
Mathias M, Coelho-Landell C, Scott-Boyer M, Lacroix S, Morine M, Salomao R, et al.
Mol Nutr Food Res
. 2018 Jan;
62(6):e1700613.
PMID: 29368422
Scope: Micronutrients are in small amounts in foods, act in concert, and require variable amounts of time to see changes in health and risk for disease. These first principles are...
3.
Mitchell E, Conus N, Kaput J
Neurosci Biobehav Rev
. 2014 Sep;
47:307-20.
PMID: 25173634
The B vitamins folic acid, vitamin B12 and B6 are essential for neuronal function, and severe deficiencies have been linked to increased risk of neurodevelopmental disorders, psychiatric disease and dementia....
4.
Firmansyah A, Dwipoerwantoro P, Kadim M, Alatas S, Conus N, Lestarina L, et al.
Asia Pac J Clin Nutr
. 2011 Mar;
20(1):69-76.
PMID: 21393113
Bifidobacterium longum (BL999), Lactobacillus rhamonosus (LPR), prebiotics (inulin and fructo-oligosaccharides), and long-chain polyunsaturated fatty acids (LCPUFA) are believed to have health benefits. In a randomized, double-blind, controlled trial we compared...
5.
Cullinane C, Natoli A, Hui Y, Conus N, Jackson S, Bruggen J, et al.
Mol Cancer Ther
. 2010 May;
9(5):1461-8.
PMID: 20442311
The novel KIT inhibitor nilotinib is currently being evaluated for its clinical utility in the treatment of gastrointestinal stromal tumor. However, the effects of nilotinib in cells expressing commonly occurring...
6.
Dorow D, Cullinane C, Conus N, Roselt P, Binns D, McCarthy T, et al.
Eur J Nucl Med Mol Imaging
. 2006 Feb;
33(4):441-52.
PMID: 16450138
Purpose: This study was designed as "proof of concept" for a drug development model utilising multi-tracer serial small animal PET imaging to characterise tumour responses to molecularly targeted therapy. Methods:...
7.
Cullinane C, Dorow D, Kansara M, Conus N, Binns D, Hicks R, et al.
Cancer Res
. 2005 Nov;
65(21):9633-6.
PMID: 16266981
In vivo models that recapitulate oncogene-dependent tumorigenesis will greatly facilitate development of molecularly targeted anticancer therapies. We have developed a model based on activating mutations in c-KIT in gastrointestinal stromal...